On the use of partial AUC as an early exposure metric

European Journal of Pharmaceutical Sciences

Volumn 10, Issue 2, 2000, Pages 91-95

  Dokoumetzidis, Aristides ^a   Macheras, Panos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Bioequivalence; Exposure; Metric; Partial AUC

Indexed keywords

AREA UNDER THE CURVE; BIOEQUIVALENCE; DRUG ABSORPTION; EXPOSURE; NOTE; PRIORITY JOURNAL;

ALGORITHMS; AREA UNDER CURVE; COMPUTER SIMULATION; PHARMACOKINETICS;

EID: 0034112938     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(99)00095-0     Document Type: Note

References (14)

1. AAPS News, 1998. American Association of Pharmaceutical Scientists (AAPS) News, 1, 3.
2. Chen M.L. An alternative approach for assessment of rate of absorption in bioequivalence studies. Pharm. Res. 9:1992;1380-1385.
3. Elkoshi Z. Dissolution specifications based on release rates. J. Pharm. Sci. 88:1999;434-444.
4. Endrenyi L., Al-Skaikh P. Sensitive and specific determination of the equivalence of absorption rates. Pharm. Res. 12:1995;1856-1864.
5. Endrenyi L., Csizmadia F., Tothfalusi L., Balch A.H., Chen M.L. The duration of measuring partial AUCs for the assessment of bioequivalence. Pharm. Res. 15:1998;399-404.
6. Endrenyi L., Csizmadia F., Tothfalusi L., Chen M.L. Metrics comparing simulated early concentration profiles for the determination of bioequivalence. Pharm. Res. 15:1998;1292-1299.
7. Macheras P., Symillides M., Reppas C. The cutoff time point of the partial area method for assessment of rate of absorption in bioequivalence studies. Pharm. Res. 11:1994;831-834.
8. Macheras P., Symillides M., Reppas C. An improved intercept method for the assessment of rate in bioequivalence studies. Pharm. Res. 13:1996;1755-1758.
9. Rostami-Hodjegan A., Jackson P.R., Tucker G.T. Sensitivity of indirect metrics for assessing "rate" in bioequivalence studies - Moving the "goalposts" or changing the "game" J. Pharm. Sci. 83:1994;1554-1557.
10. Sheiner L.B., Stanski D.R., Vozeh S., Miller R.D., Ham J. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to D-tubocurarine. Clin. Pharmacol. Ther. 25:1979;358-371.
11. max/AUC is an effective metric in investigations of bioequivalence. Pharm. Res. 12:1995;937-942.
12. Tozer T.N., Bois F.Y., Hauck W.W., Chen M., Williams R. Absorption rate vs. exposure: which is more useful for bioequivalence testing? Pharm. Res. 13:1996;453-456.
13. Williams R., 1999. The role of bioequivalence studies in assuring drug product quality. In: Challenges in the Design and Evaluation of Bioequivalence Studies. Workshop, 8-10 March, Frankfurt/Main.
14. Yu Z., Tse F.L.S. Pharmacokinetics and Pharmacodynamics Modeling Using Matlab, Part II. 1994;Sandoz Research Institute, New Jersey, NJ.